Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Aug 16;1(3):30.
doi: 10.3390/mps1030030.

Molecular Analysis of PKU-Associated PAH Mutations: A Fast and Simple Genotyping Test

Affiliations

Molecular Analysis of PKU-Associated PAH Mutations: A Fast and Simple Genotyping Test

Manuela Tolve et al. Methods Protoc. .

Abstract

Neonatal screening for phenylketonuria (PKU, OMIM: 261600) was introduced at the end of the 1960s. We developed a rapid and simple molecular test for the most frequent phenylalanine hydroxylase (PAH, Gene ID: 5053) mutations. Using this method to detect the 18 most frequent mutations, it is possible to achieve a 75% detection rate in Italian population. The variants selected also reach a high detection rate in other populations, for example, 70% in southern Germany, 68% in western Germany, 76% in Denmark, 68% in Sweden, 63% in Poland, and 60% in Bulgaria. We successfully applied this confirmation test in neonatal screening for hyperphenylalaninemias using dried blood spots and obtained the genotype in approximately 48 h. The method was found to be suitable as second tier test in neonatal screening for hyperphenylalaninemias in neonates with a positive screening test. This test can also be useful for carrier screening because it can bypass the entire coding sequence and intron-exon boundaries sequencing, thereby overcoming the questions that this approach implies, such as new variant interpretations.

Keywords: PKU mutation analysis; PKU screening; phenylalanine hydroxylase deficiency; phenylketonuria.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Compound heterozygosity electropherogram of p.Arg243* and p.Arg261* of Multiplex SNaPshot Reaction I. (1) and (2) heterozygosity of R1P1probe (p.Arg243*, c.727C>T); (3) and (4) heterozygosity of R1P2 probe (p.Arg261*, c.781C>T); (5) wild type R1P3r (p.Arg252Trp, c.754C>T); (6) wild type R1P4r (c.842+1G>A); (7) wild type R1P5r (p.Arg261Gln, c.782G>A); (8) wild type R1P6 (p.Pro281Leu, c.842C>T and p.Pro281Arg, c.842C>G).
Figure 2
Figure 2
Homozygosity electropherogram of p.Leu48Ser of Multiplex SNaPshot Reaction II. (1) wild type R2P1r probe (p.Ala300Ser, c.898G>T); (2) homozygosity R2P2 probe (p.Leu48Ser, c.143T>C); (3) wild type R2P3r probe (p.Arg158Gln, c.473G>A); (4) wild type R2P4r probe (p.Phe55del, c.163_165delTT); (5) wild type R2P5 probe (c.441+5G>T).
Figure 3
Figure 3
Heterozygosity electropherogram of p.Arg408Trp of Multiplex SNaPshot Reaction III. (1) wild type R3P1 probe (p.Ala403Val, c.899C>T); (2) wild type R3P2r probe (p.Tyr414Cys, c.1241A>G); (3) and (4) heterozygosity of R3P3r probe (p.Arg408Trp; c.1222C>T); (5) wild type R3P4 probe (p.Glu390Gly, c.1169A>G); (6) wild type R3P5 probe (c.1315+1G>A); 7) wild type R3P6r probe (c.1066-11G>A).
Figure 4
Figure 4
Wild type electropherogram of Multiplex SNaPshot Reaction IV. (1) wild type R4P1r probe (p.Val245Ala, c.734T>C and p.Val245Glu, c.734T>A); (2) wild type R4P2 probe (p.Ala300Val, c.899C>T); (3) wild type R4P3 probe (p.Tyr414Tyr; c.1242C>T); (4) wild type R4P4 (p.Val245Ile, c.733G>A and p.Val245Leu, c.733G>C); (5) wild type R4P5 probe (p.Arg408Gln, c.1223G>A); (6) wild type R4P6 probe (c.842+2T>A); (7) wild type R4P7 probe (p.Pro281Ser, c.841C>T andp.Pro281Ala, c.841C>G).
Figure 5
Figure 5
Aberrant Pattern: the picture shows how the use of more than one probe can be helpful to reveal correct genotype in case of an ambiguous pattern. When probe R1P4r shows a T/T on the electropherogram two genotypes are possible: c.842+1G>A and c.841_842delCCG. Using other probes present in Reaction mix I and IV we can distinguish the two genotypes: If c.842+1G>A is present, R4P7r shows C/C genotype (c) and R1P6 C/C genotype (a). If c.841_842delCCG is present R4P7 will be T/T (d), R1P4r T/T and peak corresponding to RIp6 will be absent (b).

References

    1. Scriver C.R., Kaufman S. The Metabolic and Molecular Bases of Inherited Disease. 8th ed. McGraw-Hill; New York, NY, USA: 2001. The hyperphenylalaninemias; pp. 1667–1724.
    1. Guldberg P., Rey F., Zschocke J., Romano V., François B., Michiels L., Ullrich K., Hoffmann G.F., Burgard P., Schmidt H., et al. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype-based prediction of metabolic phenotype. Am. J. Hum. Genet. 1998;63:71–79. doi: 10.1086/301920. - DOI - PMC - PubMed
    1. Bénit P., Rey F., Blandin-Savoja F., Munnich A., Abadie V., Rey J. The mutant genotype is the main determinant of the metabolic phenotype in phenylalanine hydroxylase deficiency. Mol. Genet. Metab. 1999;68:43–47. doi: 10.1006/mgme.1999.2886. - DOI - PubMed
    1. Blau N., Shen N., Carducci C. Molecular genetics and diagnosis of phenylketonuria: State of the art. Expert Rev. Mol. Diagn. 2014;6:655–671. doi: 10.1586/14737159.2014.923760. - DOI - PubMed
    1. Brosco J.P., Jeffrey P., Diane B.P. The political history of PKU: reflections on 50 years of newborn screening. Pediatrics. 2013;132:987–989. doi: 10.1542/peds.2013-1441. - DOI - PMC - PubMed

LinkOut - more resources